Otsuka
Updates & Highlights
Recent Openings
View all 2 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Otsuka?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentOtsuka Pharmaceutical Co. v. Lupin Ltd. (Fed. Cir. 2026)
Otsuka Pharmaceutical Co. v. Lupin Ltd. (Fed. Cir. 2026)
JD Supra · 4 days ago
Michio Otsuka
Michio Otsuka
Transfermarkt · 5 days ago
Otsuka closes $700M deal for psych drug maker Transcend
Otsuka closes $700M deal for psych drug maker Transcend
Crain's New York Business · 5 days ago
#Ad paid and presented by Otsuka Precision Health. A path forward in depression care
#Ad paid and presented by Otsuka Precision Health. A path forward in depression care
BBC · 8 days ago
Otsuka America finishes $700M acquisition of Transcend Therapeutics
Otsuka America finishes $700M acquisition of Transcend Therapeutics
ROI-NJ · 8 days ago
Otsuka Completes $700 Million Acquisition Of Transcend Therapeutics
Otsuka Completes $700 Million Acquisition Of Transcend Therapeutics
Pulse 2.0 · 11 days ago
Transcend Therapeutics: Otsuka Pharmaceutical Completes Acquisition To Advance PTSD Treatment Development
Transcend Therapeutics: Otsuka Pharmaceutical Completes Acquisition To Advance PTSD Treatment Development
Pulse 2.0 · 11 days ago
Otsuka Completes Transcend Therapeutics Acquisition, Advancing Next-Gen Neuropsychiatric Treatments
Otsuka Completes Transcend Therapeutics Acquisition, Advancing Next-Gen Neuropsychiatric Treatments
Contract Pharma · 11 days ago
Otsuka Completes $700M Acquisition of Transcend Therapeutics to Expand PTSD Pipeline
Otsuka Completes $700M Acquisition of Transcend Therapeutics to Expand PTSD Pipeline
citybiz · 11 days ago
Otsuka Completes Acquisition of Transcend Therapeutics to Advance Next-Generation Neuropsychiatric Treatments
Otsuka Completes Acquisition of Transcend Therapeutics to Advance Next-Generation Neuropsychiatric Treatments
The Joplin Globe · 11 days ago
Otsuka Completes Acquisition of Transcend Therapeutics to Advance Next-Generation Neuropsychiatric Treatments
Otsuka Completes Acquisition of Transcend Therapeutics to Advance Next-Generation Neuropsychiatric Treatments
Yahoo Finance · 11 days ago
Transcend Therapeutics Announces Completion of Acquisition by Otsuka Pharmaceutical
Transcend Therapeutics Announces Completion of Acquisition by Otsuka Pharmaceutical
PR Newswire · 11 days ago
Harbour BioMed partners Otsuka on new T-cell therapy
Harbour BioMed partners Otsuka on new T-cell therapy
MSN · 13 days ago
Otsuka Reports Phase III Data Showing VOYXACT Preserved Kidney Function in IgA Nephropathy
Otsuka Reports Phase III Data Showing VOYXACT Preserved Kidney Function in IgA Nephropathy
BioSpectrum Asia · 15 days ago
Otsuka says kidney disease drug preserves function in late-stage study
Otsuka says kidney disease drug preserves function in late-stage study
MSN · 17 days ago
Otsuka says kidney disease drug preserves function in late-stage study
Otsuka says kidney disease drug preserves function in late-stage study
MSN · 18 days ago
Otsuka’s Voyxact preserves kidney function at 12 months
Otsuka’s Voyxact preserves kidney function at 12 months
Yahoo · 18 days ago
Otsuka Establishes "Heatstroke Countermeasure Industry-Government-Academia Consortium" with the National Institute for Environmental Studies and Other Partners｜June 5, 2026｜News Releases | Otsuka Pharmaceutical Co., Ltd.
Otsuka Establishes "Heatstroke Countermeasure Industry-Government-Academia Consortium" with the National Institute for Environmental Studies and Other Partners｜June 5, 2026｜News Releases | Otsuka Pharmaceutical Co., Ltd.
otsuka.co.jp · 18 days ago
Otsuka’s Voyxact preserves kidney function at 12 months
Otsuka’s Voyxact preserves kidney function at 12 months
Clinical Trials Arena · 19 days ago
Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data
Otsuka energizes IgA neuropathy space with new Phase 3 Voyxact data
BioSpace · 19 days ago